Digital Health Startups

Binkey helps businesses and healthcare consumers use tax-advantaged accounts such as FSAs and HSAs to save on healthcare expenses and manage payments. It operates at the intersection of healthcare and financial wellness, focused on patients and consumers in the US.

1 investor

Biobase builds data infrastructure to make clinical data accessible across the healthcare value chain, positioning itself as the "rails" for precision medicine rather than a data marketplace. It serves participants in the healthcare and life sciences sector by connecting data generated during care with downstream medicine development.

1 investor

Biocom (operated by Allostar Inc.) offers scientific biodata analysis services—such as comprehensive metabolic function testing, food intolerance analysis, and stress/aging assessments—paired with personalized diet, nutrition, sleep, and exercise solutions, health foods, and management challenge programs. It sells these tests, supplements, and membership benefits to consumers through its official online store in South Korea.

1 investor

Endobits is clinical decision-support software that runs on top of FDA-cleared continuous glucose monitors to help qualified healthcare professionals and clinics manage glucose-related conditions such as dysglycemia and pre-diabetes. The software supports clinician-directed care and references CPT codes for billing, while providers retain full clinical authority.

1 investor

Bio Design Lab uses synthetic biology to engineer viral vector components, offering retroviral and lentiviral vectors designed to shift transgene integration away from proto-oncogenes for improved safety and enhanced transduction efficiency. Its vectors support gene therapies, cell therapies (including T and NK cells), vaccine platforms, and protein-producing cell lines.

1 investor

Biodesix is a diagnostic solutions company that develops and provides advanced diagnostic tests, with a focus on lung disease and cancer, to support clinical decisions and personalized patient care. It also offers custom diagnostic development services to biopharmaceutical, life sciences, and research institutions.

1 investor

BioDigital builds an interactive 3D software platform for visualizing human anatomy, diseases, and treatments, with a cloud model library of over 14,000 anatomical structures and 600+ health conditions. It serves health education and life sciences organizations with tools for authoring custom anatomy experiences and 3D quizzes.

1 investor

Bioelectrix develops a novel electrical stimulation technology to accelerate wound healing by delivering stable, controlled electrical signals to tissue. The company targets diabetic foot ulcers and other chronic wounds, with initial focus on patients for whom small wounds can become life-threatening complications.

1 investor

Biofourmis provides technology-enabled solutions and a platform for AI-driven in-home patient care, using wearable biosensors and remote monitoring to deliver and transition patients across levels of care. It serves healthcare providers and partners, aiming to reduce hospital readmissions and cost of care.

1 investor

Biogazelle develops RNA biomarker discovery and transcriptome profiling solutions for clinical research and diagnostics. The company specializes in innovative RNA analysis technologies for medical applications.

1 investor

Biogenera develops BGA002, an anti-tumor therapeutic candidate targeting neuroblastoma and rhabdomyosarcoma, which primarily affect children and adolescents. The company is advancing the drug through clinical development with a structured regulatory pathway in Europe.

1 investor

1 investor

BioKine develops immunotherapy drug candidates targeting cancer metastasis and treatment resistance, with its lead product BL-8040 in multiple clinical trials including stem cell mobilization, acute myeloid leukemia, and pancreatic carcinoma.

1 investor

Groupe Biolam operates a network of medical biology laboratories that provide diagnostic analyses and support patients in their care pathway. It runs 28 labs in Hauts-de-France, 13 in Normandy, and 10 in Île-de-France.

1 investor

BioLamina develops full-length human recombinant laminin proteins and related cell culture substrates for research and clinical applications. The company's products support the growth and differentiation of pluripotent stem cells, tissue-specific cells, and organoid development in both 2D and 3D culture environments.

1 investor

Bioline Rx develops therapies for patients with cancer and rare diseases, leveraging a team with expertise spanning drug development from chemistry through clinical trials to commercialization.

1 investor

Biomarq Health develops a wearable, injectable multi-analyte biosensor platform that continuously monitors biochemical markers such as glucose, lactate, ketones, cortisol, and kidney-related analytes from a single sensor. Its first product targets affordable continuous glucose monitoring for people with type 1, type 2, and pre-diabetes, with planned applications in chronic kidney disease, pregnancy monitoring, and healthspan research.

1 investor

Biomarx develops automated liquid biopsy diagnostics using biosensing technologies for early cancer and disease detection, delivering test results in under two hours at low cost. Its products target clinicians and healthcare providers seeking rapid, affordable precision diagnostics for personalised medicine.

1 investor

Biome Resources develops Kronobiotic, a supplement designed to balance intestinal microbiota. The company offers health-focused products sold through online channels.

1 investor

BioMech develops wireless, noninvasive motion sensors and analytics software (BioMech Lab and BioMech AI) that capture and stream three-dimensional motion in real time. Its platform serves healthcare, sports/wellness, and industrial markets to quantify and improve movement outcomes.

1 investor

Provides biomedical testing services focused on gut microbiome analysis combined with personalized probiotic treatments to address common urban health issues. The company bases its approach on genetic testing and proprietary probiotic formulations tailored to individual needs.

1 investor

bioMérieux develops in vitro diagnostic solutions for clinical laboratories and healthcare professionals, covering areas such as antimicrobial stewardship, sepsis, and infectious disease detection. It also provides diagnostics for food safety and quality and pharmaceutical quality control.

1 investor

Biomine Health is South Africa's microbiome testing and treatment company, providing personalized health insights based on microbiome analysis to help people understand and optimize their gut health. The company serves individuals seeking proactive health management through microbiome-based diagnostics and treatments.

1 investor

Bioness Medical develops neuromodulation systems, robotic systems, and software-based therapy programs for patients with central nervous system disorders and orthopedic injuries. The company's offerings aim to improve patient outcomes and enhance efficiency for healthcare providers.

1 investor